SAN CLEMENTE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial ...
4don MSN
ICU Medical updates 2025 EPS guidance to $7.35–$7.65 amid strong Q3 growth and cost controls
Q3 2025 Management View Vivek Jain, CEO & Chairman, reported Q3 revenue of $533 million, representing 5% organic growth, with ...
StockStory.org on MSN
ICU Medical’s (NASDAQ:ICUI) Q3: Strong Sales
Medical device company ICU Medical (NASDAQ:ICUI) reported Q3 CY2025 results , but sales fell by 8.9% year on year to $537 ...
Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of ICU Medical ...
SAN CLEMENTE, Calif. (AP) — SAN CLEMENTE, Calif. (AP) — ICU Medical Inc. (ICUI) on Thursday reported a loss of $3.4 million in its third quarter. On a per-share basis, the San Clemente, ...
The mislabeled Potassium Chloride Inj. 20 mEq bags contain an overwrap label with Lot# 1023172 (NDC# 0990-7074-26) and an expiration date of 01-31-2026. ICU Medical is recalling 1 lot of Potassium ...
San Clemente-based ICU Medical Inc. (Nasdaq: ICUI) has completed its largest-ever acquisition, for fellow device maker Smiths Medical in a $2.4 billion cash and stock deal. ICU, a maker of devices for ...
Fintel reports that on June 17, 2024, Raymond James upgraded their outlook for ICU Medical (NasdaqGS:ICUI) from Market Perform to Outperform. As of June 12, 2024, the average one-year price target for ...
After unveiling plans last month to sell its medical device business for $2 billion, the U.K. technology group Smiths announced that a better deal has come along from a once-previous suitor. The ...
ICU Medical develops disposable medical connection systems for use in intravenous (IV) therapy applications. The company's IV connectors are designed to prevent accidental disconnection of IV lines ...
ICU Medical Inc., a supplier of infusion therapy-related medical equipment, reported fourth quarter revenue and profit that topped analysts’ expectations. Yet, investors are unhappy, sending the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results